| 19.54 0.15 (0.77%) | 04-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 23  |
1-year : | 26.87 |
| Resists | First : | 19.7 |
Second : | 23 |
| Pivot price | 18.93 |
|||
| Supports | First : | 18.84 |
Second : | 18.31 |
| MAs | MA(5) : | 19.05 |
MA(20) : | 18.95 |
| MA(100) : | 19.89 |
MA(250) : | 21.37 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 82.9 |
D(3) : | 61.1 |
| RSI | RSI(14): 55.3 |
|||
| 52-week | High : | 27.71 | Low : | 16.37 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ FMS ] has closed Bollinger Bands are 39.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 19.62 - 19.7 | 19.7 - 19.77 |
| Low: | 19.03 - 19.12 | 19.12 - 19.21 |
| Close: | 19.39 - 19.53 | 19.53 - 19.67 |
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fri, 19 Apr 2024
Environmental Impact & Sustainability | Fresenius Medical Care - Fresenius Medical Care
Thu, 18 Apr 2024
Fresenius Medical Care (NYSE:FMS) Sees Unusually-High Trading Volume - MarketBeat
Wed, 17 Apr 2024
Fresenius Medical Care AG Announces Annual Dividend of $0.44 (NYSE:FMS) - MarketBeat
Tue, 16 Apr 2024
Investors in Fresenius Medical Care (ETR:FME) have unfortunately lost 44% over the last five years - Simply Wall St
Sat, 06 Apr 2024
Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19 - Yahoo Finance
Mon, 25 Mar 2024
What Makes Fresenius Medical Care AG (FMS) a Potential Investment? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 587 (M) |
| Shares Float | 199 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 7.3 (%) |
| Shares Short | 1,100 (K) |
| Shares Short P.Month | 813 (K) |
| EPS | 0.91 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 46.41 |
| Profit Margin | 2.5 % |
| Operating Margin | 9.9 % |
| Return on Assets (ttm) | 2.7 % |
| Return on Equity (ttm) | 4.8 % |
| Qtrly Rev. Growth | -0.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 33.14 |
| EBITDA (p.s.) | 4.05 |
| Qtrly Earnings Growth | 35.2 % |
| Operating Cash Flow | 2,630 (M) |
| Levered Free Cash Flow | 1,330 (M) |
| PE Ratio | 21.47 |
| PEG Ratio | 8.3 |
| Price to Book value | 0.42 |
| Price to Sales | 0.58 |
| Price to Cash Flow | 4.35 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|